A proteomic study of TAR-RNA binding protein (TRBP)-associated factors

  • Ya-Hui Chi1, 3,

    Affiliated with

    • Oliver John Semmes2 and

      Affiliated with

      • Kuan-Teh Jeang3Email author

        Affiliated with

        Cell & Bioscience20111:9

        DOI: 10.1186/2045-3701-1-9

        Received: 27 January 2011

        Accepted: 25 February 2011

        Published: 25 February 2011



        The human TAR RNA-binding protein, TRBP, was first identified and cloned based on its high affinity binding to the small hairpin trans-activation responsive (TAR) RNA of HIV-1. TRBP has more recently been found to be a constituent of the RNA-induced silencing complex (RISC) serving as a Dicer co-factor in the processing of the ~70 nucleotide pre-microRNAs(miRNAs) to 21-25 nucleotide mature miRNAs.


        Using co-immunoprecipitation and protein-identification by mass spectrometry, we characterized intracellular proteins that complex with TRBP. These interacting proteins include those that have been described to act in protein synthesis, RNA modifications and processing, DNA transcription, and cell proliferation.


        Our findings provide a proteome of factors that may cooperate with TRBP in activities such as miRNA processing and in RNA interference by the RISC complex.



        TAR-RNA binding protein 2


        RNA-induced silencing complex


        trans-activation responsive element.


        MicroRNAs (miRNAs) are important regulators of cellular development, differentiation, proliferation, apoptosis, metabolism, and oncogenesis [14]. Cellular miRNAs have also been proposed to function in restricting virus infection of cells [511]. The biogenesis of miRNAs in eukaryotic cells has been reviewed extensively elsewhere [12, 13]. In brief, RNA polymerase II transcribed primary microRNA transcripts (pri-miRNA) are processed by Drosha in the nucleus to pre-miRNA precursors which are then processed by Dicer in the cytoplasm to mature miRNAs. In analyzing miRNA processing, it was noted that a cellular protein, TAR RNA-binding protein TRBP, binds directly to Dicer [1417] and is important to the activity of miRNA-mediated RNA-silencing. Moreover, a TRBP-Ago2 composed RNA-induced silencing complex (RISC) has been shown to be needed for optimal miRNA-guided post-transcriptional silencing [18].

        TRBP contains two double-stranded RNA binding domains (RBD) [17] and was originally characterized and cloned based on its high affinity binding to the HIV-1 small hairpin leader RNA, TAR [1921]. Consistent with the notion of miRNA-mediated restriction of viral infection in mammalian cells, loss of TRBP activity through its sequestration by TAR RNA resulted in the enhanced replication of HIV-1 in human cells [22]. To date, TRBP is considered to act inside cells through at least three different mechanisms: it can promote the translation of TAR RNA-containing viral RNAs [23]; it can directly bind and inhibit the interferon (IFN)-induced double-stranded RNA (dsRNA)-activated protein kinase R (PKR) [24]; and as mentioned above, it can be a Dicer co-factor in the miRNA/siRNA RNAi pathway. To gain additional insight into TRBP function, we sought to identify human cellular factors that associate with TRBP. Here, using co-immunoprecipitation (co-IP) and protein-identification by mass spectrometry, we report proteins in a TRBP-proteome.

        Figure 1A shows the Coomassie blue stained profile of proteins that co-IP with TRBP. After treating with RNase A, the majority (> 80%) of the co-IP products were reduced in amounts, suggesting that many TRBP-interacting partners in the co-IP are indirectly linked via RNA-association (silver stain, Figure 1B). Next, we compared "Mock" to "TRBP" samples based on silver staining; and we excised the corresponding Coomassie blue stained protein bands that were enhanced in the TRBP sample. These bands were then analyzed by LC-MS/MS spectrometry (Figure 1A). The corresponding gel bands from the "Mock" sample were also excised and analyzed in parallel. By subtracting the "Mock" protein identification data from the "TRBP" protein identification data, 160 "TRBP-associated" factors were identified (Additional file 1, Table S1). The functional relevance (according to the p value computed by the Ingenuity Systems algorithm using right-tailed Fisher Exact Test) of each category of protein factors to established pathways is diagrammed in Figure 2, and the protein identities present in each functional category are listed in Table 1. Similar to a previous report [25], our results show that TRBP is significantly associated with factors in the protein synthesis machinery that is constituted by the 80S ribosome [20 out of 32 proteins (RPSs; ribosomal protein, small subunits) of the 40S ribosomal subunits, and 24 out of 46 proteins (RPLs; ribosomal protein, large subunits) of the 60S ribosomal subunit were identified] [26]. Also identified were several translation elongation factors (e.g. ABCF1, EEF1A2, EIF2AK2 and EIF2S1) (Table 1).
        Figure 1

        Gel electrophoresis profile of the TRBP-interacting proteins. (A) Total cell lysates from HeLa cells overexpressing Flag-TRBP were collected and immunoprecipitated with monoclonal anti-Flag agarose. Flag-TRBP and its interacting proteins were eluted with 3X Flag polypeptides and were subjected to sodium dodecyl-sulfate (SDS) gel electrophoresis followed by colloidal Coomassie staining. Co-immunoprecipitated products using cell lysates with mock transfection were compared. Fifteen gel bands as marked from the mock and TRBP eluents were excised for mass spectrometry analyses. (B) The immunoprecipitated Flag-agarose beads were treated with RNase A for 1 hour and washed three times with RIPA buffer. The remaining binding proteins were eluted with 3X Flag polypeptides and analyzed by gel-electrophoresis and silver staining. Please see Additional file 2, supplementary Materials and Methods, for detailed methodology.

        Figure 2

        Functional categorization of the TRBP-interacting proteins. Categorization of the molecular function of the 160 TRBP interacting proteins was done using the Ingenuity Pathway Analysis software. The y-axis shows statistical relevance of the TRBP-interacting factors in the indicated functional categories. The protein identities of TRBP-associated factors in each functional category are summarized in Table 1.

        Table 1

        Functional categories of the TRBP-associated complex



        Protein Synthesis

        ABCF1, EEF1A2, EIF2AK2, EIF2S1, PTBP1, RPL3, RPL4, RPL5, RPL6, RPL7, RPL9, RPL11, RPL15, RPL18, RPL21, RPL22, RPL24, RPL30, RPL32, RPL34, RPL35, RPL18A, RPL23A, RPL27A, RPL29 (includes EG:6159), RPL31 (includes EG:6160), RPL7A (includes EG:6130), RPS2, RPS5, RPS6, RPS9, RPS10, RPS11, RPS17 (includes EG:6218), RPS3A

        RNA Post-Transcriptional Modification


        Cellular Growth and Proliferation


        Gene Expression

        BASP1, BTF3, CDC5L, CHD4, CSDA, DDX5, DEK, EIF2S1, GTF3C1, GTF3C3, GTF3C4, HMGA1, HNRPAB, IGHMBP2, PARP1, PHB (includes EG:5245), RBM39, RPL6, SOX21, TARBP2, TOP1, TOP2A

        Cell Death

        DDX5, DIDO1, DNAJA3, EEF1A2, EIF2AK2, EIF2S1, GNL3, HIST1H1C, HMGA1, HNRPA1, HNRPC, HSPA1B, PARP1, PHB (includes EG:5245), PPP1R9B, PRPF19, RBBP4, RPLP0 (includes EG:6175), RPS3A, SLC2A1, TOP1, TOP2A

        DNA Replication, Recombination, and Repair


        Cell Cycle

        CDC5L, EIF2AK2, GNL3, HMGA1, NOL1, PARP1, PES1, PHB (includes EG:5245), PPP1R9B, PRMT5, RPL5, RPL11, RPL23, TOP2A



        Skeletal and Muscular Disorders

        RPL5, RPL11, RPL23

        Cell Morphology


        Cellular Function and Maintenance/Connective Tissue Development and Function

        EIF2AK2, EIF2S1

        Viral Function

        AKAP13, EIF2AK2, HMGA1, PARP1, SFRS1

        Although previous reports implicated TRBP as active primarily in the cytoplasm, our mass spectrometry results (Additional file 2. Supplementary Materials and Methods) identified several TRBP-interacting nuclear factors which are known to participate in processes including RNA splicing, cellular growth and proliferation and gene transcription (Figure 2, Table 1; and Additional file 1, Table S1). For example, EFTUD2, HNRPC, PRPF8, PTBP1, SFRS1, SYNCRIP, SNRPD1, SNRPD3 and U2AF1 are components of the small nuclear ribonucleoprotein (snRNPs) that are involved in splicing of pre-mRNAs. Related to gene transcription, TRBP-associated proteins include those found to be active in RNA polymerase II- and III-dependent transcription (Additional file 1, Table S1). Additionally, a TRBP-associated factor, Sox21, is a HMG-box transcription factor that acts in a complex array of repressive and activating transcriptional processes in embryonic stem cells [27]. The transcription co-activator HMGA1 was also identified in our proteomic data (Table 1). Whether TRBP participates in the determination of pluripotency through Sox21 requires further study.

        Recently, TRBP truncating mutations were found in human cancers with microsatellite instability [28]. Evidence exists which supports the notion that impaired miRNA processing and destabilization of the DICER1 protein are correlated with tumorigenesis [28]. Because TRBP is known to interact with Dicer and to be involved in mRNA processing, how TRBP and TRBP-interacting proteins contribute to oncogenesis merits future investigation. The current TRBP proteome provides a starting point for initiating those explorations. Our study describes the TRBP-proteome in HeLa cells. Although TRBP was originally identified as the HIV-1 TAR RNA-binding protein, its more recently characterized function in microRNA biogenesis and RISC-activity is widely conserved in all cell types (e.g. epithelial, hematopoietic, mesenchymal cells etc...). Thus, a HeLa-like TRBP-proteome is likely to be found in all types of human cells. We realize that systematic functional validation of the currently identified TRBP proteome will be necessary in order to clarify the biological relevance of each factor. Indeed, some of the TRBP-interacting proteins are being currently characterized.



        Work in the KTJ laboratory was supported in part by NIAID/NIH intramural funds and by the Intramural AIDS Targeted Anti-viral Program (IATAP).

        Authors’ Affiliations

        Institute of Cellular and System Medicine, National Health Research Institutes
        Department of Microbiology and Molecular Cell Biology, The Leroy T. Canoles Jr. Cancer Research Center,, Eastern Virginia Medical School
        Molecular Virology Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health


        1. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM: MicroRNA expression and function in cancer. Trends Mol Med. 2006, 12: 580-587. 10.1016/j.molmed.2006.10.006View ArticlePubMed
        2. Svoboda P, Flemr M: The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency. EMBO Rep. 2010, 11: 590-597. 10.1038/embor.2010.102PubMed CentralView ArticlePubMed
        3. Lewis MA, Steel KP: MicroRNAs in mouse development and disease. Semin Cell Dev Biol. 2010, 21: 774-780. 10.1016/j.semcdb.2010.02.004PubMed CentralView ArticlePubMed
        4. Yeung ML, Bennasser Y, Jeang KT: miRNAs in the biology of cancers and viral infections. Curr Med Chem. 2007, 14: 191-197. 10.2174/092986707779313417View ArticlePubMed
        5. Berkhout B, Jeang KT: RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem. 2007, 282: 26641-26645. 10.1074/jbc.R700023200View ArticlePubMed
        6. Watanabe Y, Kishi A, Yachie N, Kanai A, Tomita M: Computational analysis of microRNA-mediated antiviral defense in humans. FEBS Lett. 2007, 581: 4603-4610. 10.1016/j.febslet.2007.08.049View ArticlePubMed
        7. Yeung ML, Benkirane M, Jeang KT: Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?. Retrovirology. 2007, 4: 74. 10.1186/1742-4690-4-74PubMed CentralView ArticlePubMed
        8. Grassmann R, Jeang KT: The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta. 2008, 1779: 706-711.PubMed CentralView ArticlePubMed
        9. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007, 315: 1579-1582. 10.1126/science.1136319View ArticlePubMed
        10. Chable-Bessia C, Meziane O, Latreille D, Triboulet R, Zamborlini A, Wagschal A: Suppression of HIV-1 replication by microRNA effectors. Retrovirology. 2009, 6: 26. 10.1186/1742-4690-6-26PubMed CentralView ArticlePubMed
        11. Strebel K, Luban J, Jeang KT: Human cellular restriction factors that target HIV-1 replication. BMC Med. 2009, 7: 48. 10.1186/1741-7015-7-48PubMed CentralView ArticlePubMed
        12. Jaskiewicz L, Filipowicz W: Role of Dicer in posttranscriptional RNA silencing. Curr Top Microbiol Immunol. 2008, 320: 77-97. full_textPubMed
        13. Ambros V: The functions of animal microRNAs. Nature. 2004, 431: 350-355. 10.1038/nature02871View ArticlePubMed
        14. Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A: TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005, 6: 961-967. 10.1038/sj.embor.7400509PubMed CentralView ArticlePubMed
        15. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K: TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005, 436: 740-744. 10.1038/nature03868PubMed CentralView ArticlePubMed
        16. Kok KH, Ng MH, Ching YP, Jin DY: Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem. 2007, 282: 17649-17657. 10.1074/jbc.M611768200View ArticlePubMed
        17. Daniels SM, Melendez-Pena CE, Scarborough RJ, Daher A, Christensen HS, El FM: Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol Biol. 2009, 10: 38. 10.1186/1471-2199-10-38PubMed CentralView ArticlePubMed
        18. Watashi K, Yeung ML, Starost MF, Hosmane RS, Jeang KT: Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem. 2010, 285: 24707-24716. 10.1074/jbc.M109.062976PubMed CentralView ArticlePubMed
        19. Gatignol A, Buckler-White A, Berkhout B, Jeang KT: Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science. 1991, 251: 1597-1600. 10.1126/science.2011739View ArticlePubMed
        20. Gatignol A, Buckler C, Jeang KT: Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol Cell Biol. 1993, 13: 2193-2202.PubMed CentralView ArticlePubMed
        21. Duarte M, Graham K, Daher A, Battisti PL, Bannwarth S, Segeral E: Characterization of TRBP1 and TRBP2. Stable stem-loop structure at the 5' end of TRBP2 mRNA resembles HIV-1 TAR and is not found in its processed pseudogene. J Biomed Sci. 2000, 7: 494-506. 10.1007/BF02253365View ArticlePubMed
        22. Bennasser Y, Yeung ML, Jeang KT: HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem. 2006, 281: 27674-27678. 10.1074/jbc.C600072200View ArticlePubMed
        23. Dorin D, Bonnet MC, Bannwarth S, Gatignol A, Meurs EF, Vaquero C: The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J Biol Chem. 2003, 278: 4440-4448. 10.1074/jbc.M208954200View ArticlePubMed
        24. Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A: Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 1997, 16: 611-624. 10.1093/emboj/16.3.611PubMed CentralView ArticlePubMed
        25. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA: MicroRNA silencing through RISC recruitment of eIF6. Nature. 2007, 447: 823-828. 10.1038/nature05841View ArticlePubMed
        26. Wilson DN, Nierhaus KH: Ribosomal proteins in the spotlight. Crit Rev Biochem Mol Biol. 2005, 40: 243-267. 10.1080/10409230500256523View ArticlePubMed
        27. Chakravarthy H, Ormsbee BD, Mallanna SK, Rizzino A: Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery. FASEB J. 2011, 25: 206-218. 10.1096/fj.10-166926PubMed CentralView ArticlePubMed
        28. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet. 2009, 41: 365-370. 10.1038/ng.317PubMed CentralView ArticlePubMed

        This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.